M&A Update – May 17

– EMAN to be acquired by Samsung Display for $2.08 cash per share, 10.1% premium, $281 million
– HZNP / AMGN / FTC sued to block merger, “Amgen is disappointed by the FTC’s decision and remains committed to completing this acquisition, which will bring significant benefits to patients suffering from very serious rare diseases in the U.S. and around the world. We have been working cooperatively over the past several months to address the questions raised by the FTC’s investigative staff and believe we have overwhelmingly demonstrated that this combination poses no legitimate competitive issues”
– VLN.to / FLS court approval, closing Q3
– RUTH / DRI launched tender offer, expires June 13
– BLU / GSK set June 16 vote, cleared Competition Canada
– RXDX / MRK filed DEFM14a, vote June 15, closing Q3
– UNS.to / LKQ priced $1.4 billion of senior notes to fund acquisition
– INDT vote